Trials / Conditions / Recurrent Head and Neck Carcinoma

Recurrent Head and Neck Carcinoma

18 registered clinical trials studyying Recurrent Head and Neck Carcinoma — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy for Palliative Head and Neck Cancer Treatmen NCT06572423	Jonsson Comprehensive Cancer Center	N/A
Active Not Recruiting	Ramucirumab and Pembrolizumab vs Pembrolizumab Monotherapy in PD-L1 Positive Head and Neck Squamous-Cell Carci NCT05980000	Washington University School of Medicine	Phase 2
Active Not Recruiting	Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced NCT04514484	National Cancer Institute (NCI)	Phase 1
Terminated	Porfimer Sodium Interstitial Photodynamic Therapy With or Without Standard of Care Chemotherapy in Treating Pa NCT03727061	Roswell Park Cancer Institute	Phase 1
Completed	Stereotactic Body Radiation Therapy Using HyperArc in Treating Patients With Recurrent Head and Neck Cancer NCT03892720	Jonsson Comprehensive Cancer Center	N/A
Terminated	BGJ398 in Treating Patients With FGFR Positive Recurrent Head and Neck Cancer NCT02706691	University of Chicago	Phase 2
Suspended	Stereotactic Body Radiation Therapy or Intensity Modulated Radiation/Proton Therapy in Treating Patients With NCT03164460	M.D. Anderson Cancer Center	Phase 2
Completed	Recombinant EphB4-HSA Fusion Protein and Pembrolizumab, MK-3475 NCT03049618	University of Southern California	Phase 2
Completed	Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations NCT02646319	Mayo Clinic	EARLY_Phase 1
Active Not Recruiting	Study Evaluating a Stereotactic Boost/Treatment for Recurrent or Metastatic Cancer of the Head and Neck NCT02474368	Dana-Farber Cancer Institute	Phase 1
Active Not Recruiting	Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymph NCT02465060	National Cancer Institute (NCI)	Phase 2
Completed	Surgical Resection and Intraoperative Cesium-131 Brachytherapy for Head and Neck Cancer NCT02467738	Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University	EARLY_Phase 1
Completed	Radiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, NCT02318771	Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University	Phase 1
Completed	Viral Therapy In Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck C NCT01846091	Mayo Clinic	Phase 1
Completed	Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Can NCT01727076	National Cancer Institute (NCI)	Phase 1
Completed	Cetuximab With or Without Tivantinib in Treating Patients With Head and Neck Cancer That Is Recurrent, Metasta NCT01696955	National Cancer Institute (NCI)	Phase 2
Completed	Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfun NCT01638533	National Cancer Institute (NCI)	Phase 1
Completed	Phase Ib Study of Erlotinib Prior to Surgery in Patients With Head and Neck Cancer NCT00954226	M.D. Anderson Cancer Center	Phase 1